Skip to content

Advertisement

Articles

Page 5 of 6

  1. Content type: Research

    To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen

    Citation: Health Economics Review 2014 4:9

    Published on:

  2. Content type: Research

    In Switzerland, age is the predominant driver of solidarity transfers in risk adjustment (RA). Concerns have been voiced regarding growing imbalances in cost sharing between young and old insured due to demogr...

    Authors: Viktor von Wyl and Konstantin Beck

    Citation: Health Economics Review 2014 4:7

    Published on:

  3. Content type: Research

    While induced abortion is considered to be illegal and socially unacceptable in Nigeria, it is still practiced by many women in the country. Poor family planning and unsafe abortion practices have daunting eff...

    Authors: Bosede O Awoyemi and Jacob Novignon

    Citation: Health Economics Review 2014 4:3

    Published on:

  4. Content type: Research

    To identify associations between market factors, especially relative reimbursement rates, and the probability of surgery and cost per episode for three medical conditions (cataract, benign prostatic neoplasm, ...

    Authors: Jack Hadley, James D Reschovsky, James A O’Malley and Bruce E Landon

    Citation: Health Economics Review 2014 4:8

    Published on:

  5. Content type: Research

    In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-t...

    Authors: Dawn C Lee, Daniel Gladwell, Anthony J Hatswell, Joshua Porter, Nic Brereton, Elaine Tate and Alison L Saunders

    Citation: Health Economics Review 2014 4:6

    Published on:

  6. Content type: Research

    The prospective reimbursement of hospitals through the grouping of patients into a finite number of categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific cate...

    Authors: James Gaughan and Conrad Kobel

    Citation: Health Economics Review 2014 4:4

    Published on:

  7. Content type: Review

    The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant ...

    Authors: Inna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, Melanie Drechsler, Daniel Kalanovic, Peter Kaskel, Frank Langer, Jörg Ruof, Thorsten Ruppert and Daniel Wirth

    Citation: Health Economics Review 2014 4:2

    Published on:

  8. Content type: Research

    Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical wards (GMW) but the technology may be cost effective if it leads to significantly improved o...

    Authors: Farasat AS Bokhari, Ian Wellwood, Anthony G Rudd, Peter Langhorne, Martin S Dennis and Charles DA Wolfe

    Citation: Health Economics Review 2014 4:1

    Published on:

  9. Content type: Research

    In April 2008, specialization in gynecology and obstetrics departments was introduced in the Sennan area of Osaka prefecture in Japan that aimed at solving the problems of regional provisions of obstetrics ser...

    Authors: Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatuyoshi Saijo

    Citation: Health Economics Review 2013 3:31

    Published on:

  10. Content type: Research

    Patient-centered health care and shared decision making are of increasing importance in the management of AIDS/HIV patients and require an intensive consideration of patient preferences. The present study asse...

    Authors: Axel C Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling

    Citation: Health Economics Review 2013 3:30

    Published on:

  11. Content type: Review

    Recently the sequencing of the human genome has become a major biological and clinical research field. However, the public health impact of this new technology with focus on the financial effect is not yet to ...

    Authors: Martin Frank, Anne Prenzler, Roland Eils and J-Matthias Graf von der Schulenburg

    Citation: Health Economics Review 2013 3:29

    Published on:

  12. Content type: Research

    The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including...

    Authors: Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio

    Citation: Health Economics Review 2013 3:28

    Published on:

  13. Content type: Research

    Rotavirus gastroenteritis (RVGE) is a frequent disease in young children. The recommended German paediatric immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on th...

    Authors: Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk and Baudouin Standaert

    Citation: Health Economics Review 2013 3:27

    Published on:

  14. Content type: Research

    Respiratory syncytial virus (RSV) is a common cause of respiratory infection that is highly prevalent in infants. Severe cases of RSV infection require hospitalisation; this is most likely to occur in infant p...

    Authors: Anthony Bentley, Ivana Filipovic, Katherine Gooch and Katharina Büsch

    Citation: Health Economics Review 2013 3:18

    Published on:

  15. Content type: Research

    Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the...

    Authors: Rainel Sanchez-de la Rosa, Eliazar Sabater and Miguel A Casado

    Citation: Health Economics Review 2013 3:13

    Published on:

  16. Content type: Research

    The reliance on out-of-pocket payments for health services leads to a catastrophic burden for many households in Bangladesh. The World Health Organization suggests that risk-pooling mechanisms should be used f...

    Authors: Jahangir AM Khan and Sayem Ahmed

    Citation: Health Economics Review 2013 3:12

    Published on:

  17. Content type: Research

    The increasing prevalence of diabetes and its inadequate management results in a heavy burden of the disease for the patients, the health and the productive system and the overall community. Consequently, it i...

    Authors: Jorge F Elgart, Joaquin E Caporale, Lorena Gonzalez, Eleonora Aiello, Maximiliano Waschbusch and Juan J Gagliardino

    Citation: Health Economics Review 2013 3:11

    Published on:

  18. Content type: Research

    Myocardial infarction networks have been shown to improve guideline adherent therapy and outcomes in patients presenting with acute ST-elevation myocardial infarction (STEMI). Our objective was to assess the s...

    Authors: Ralf Birkemeyer, Anke Dauch, Alfred Müller, Manfred Beck, Henrik Schneider, Hueseyin Ince, Werner Jung and Steffen Wahler

    Citation: Health Economics Review 2013 3:10

    Published on:

  19. Content type: Research

    In contrast to other countries, surgery still represents the common invasive treatment for varicose veins in Germany. However, radiofrequency ablation, e.g. ClosureFast, becomes more and more popular in other ...

    Authors: Alexander Kuhlmann, Anne Prenzler, Jan Hacker and J-Matthias Graf von der Schulenburg

    Citation: Health Economics Review 2013 3:9

    Published on:

  20. Content type: Research

    Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to a...

    Authors: Tommi Härkänen, Timo Maljanen, Olavi Lindfors, Esa Virtala and Paul Knekt

    Citation: Health Economics Review 2013 3:8

    Published on:

  21. Content type: Research

    To examine the impact of temporary and permanent weight loss of 10% and 15% on 10-year and lifetime Medicare spending among adults with overweight and obesity aged 65 years and older. Weight loss of this magni...

    Authors: Kenneth E Thorpe, Zhou Yang, Kathleen M Long and W Timothy Garvey

    Citation: Health Economics Review 2013 3:7

    Published on:

  22. Content type: Research

    This study aimed to apply the previously validated severity index for rheumatoid arthritis (SIFRA) to prevalent rheumatoid arthritis (RA) groups in Turkey and determine the effect of RA severity on health care...

    Authors: Onur Baser, Erdem Baser, Akif Altinbas and Abdulkadir Burkan

    Citation: Health Economics Review 2013 3:5

    Published on:

  23. Content type: Research

    Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe.

    Authors: Antonio J Blasco, Pablo Lázaro, Teresa Caballero and Mar Guilarte

    Citation: Health Economics Review 2013 3:2

    Published on:

  24. Content type: Research

    Health care expenditure has been low over the years in developing regions of the world. A majority of countries in these regions, especially sub-Saharan Africa (SSA), rely on donor grants and loans to finance ...

    Authors: Jacob Novignon, Solomon A Olakojo and Justice Nonvignon

    Citation: Health Economics Review 2012 2:22

    Published on:

  25. Content type: Research

    To obtain detailed real-life data on costs and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in patients treated in Switzerland.

    Authors: Jan Zeidler, Thomas Mittendorf, Rüdiger Müller and Johannes von Kempis

    Citation: Health Economics Review 2012 2:20

    Published on:

  26. Content type: Research

    Persistent infections with human papillomavirus (HPV) are a necessary cause of cervical cancer and are responsible for important morbidity in men and women. Since 2007, HPV vaccination has been recommended and...

    Authors: Deniz Schobert, Vanessa Remy and Oliver Schoeffski

    Citation: Health Economics Review 2012 2:19

    Published on:

  27. Content type: Review

    Cost-of-illness studies (COI) can identify and measure all the costs of a particular disease, including the direct, indirect and intangible dimensions. They are intended to provide estimates about the economic...

    Authors: Nagede Costa, Helene Derumeaux, Thomas Rapp, Valérie Garnault, Laura Ferlicoq, Sophie Gillette, Sandrine Andrieu, Bruno Vellas, Michel Lamure, Alain Grand and Laurent Molinier

    Citation: Health Economics Review 2012 2:18

    Published on:

  28. Content type: Review

    It is acknowledged that economic evaluation methods as they have been developed for Health Technology Assessment do not capture all the costs and benefits relevant to the assessment of public health interventi...

    Authors: Kevin Marsh, Ceri J Phillips, Richard Fordham, Evelina Bertranou and Janine Hale

    Citation: Health Economics Review 2012 2:17

    Published on:

2017 Journal Metrics

Advertisement